Audubon Bioscience
PrivateLast Round
Crowdfunding
Oct 12, 2021
Est. Valuation
$10M
Total Funding Raised
$348,465
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Audubon Bioscience operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Crowdfunding round in October 2021.
Audubon Bioscience is a biotechnology company that operates as a biobank and contract research organization providing human biospecimens and clinical data to support precision medicine and cancer research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Audubon Bioscience Comparables
Compare Audubon Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MT Group | 86% | |
| US Biolab Corporation | 85% | |
| Sanguine Biosciences | 84% |
For institutional investors. Book with your work email.
Audubon Bioscience Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Audubon Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MicroVentures | Crowdfunding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 36% MoM, reaching 2.3K.
- Oct 12, 2021
$348K raised from MicroVentures
For institutional investors. Book with your work email.
Audubon Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Audubon Bioscience's valuation, stock price, and market status.
Is Audubon Bioscience a public or private company?
Audubon Bioscience is a private company.
What is the current stock price of Audubon Bioscience?
Audubon Bioscience is a private company, so its shares have no public market price. Caplight tracks Audubon Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Audubon Bioscience worth (valuation)?
Audubon Bioscience's valuation is estimated at $10.0M based on funding round data.
Can I buy Audubon Bioscience stock?
Audubon Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Audubon Bioscience's last funding round?
Audubon Bioscience's most recent funding round was Crowdfunding on October 12, 2021.
Who are the main investors in Audubon Bioscience?
Key investors in Audubon Bioscience include MicroVentures.
Will Audubon Bioscience IPO soon?
No public IPO plans have been announced for Audubon Bioscience.
How can I track Audubon Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Audubon Bioscience's shares on secondary markets.